About Us


Gertrude Biomedical is a biotechnology company dedicated to developing novel small molecule inhibitors of the SOX18 transcription factor complex for the treatment of serious human diseases, which depend on aberrant vasculature for their growth and spread.

Investors & Partners

At Gertrude Biomedical we welcome discussions with potential investors and partners.


© 2019 by Gertrude Biomedical Pty Ltd.